Royal Prince Alfred Hospital
Royal Prince Alfred Hospital
Sydney, New South Wales, Australia19 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease | Moderately to Severely Active Crohns Disease | Recruiting | Phase 3 | 2026-09-16 | NCT06819878 | |
| PRIORITY-CONNECT 2 Trial | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Not applicable | 2026-09-15 | NCT06976710 | |
| A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis | Moderately to Severely Active Ulcerative Colitis | Active, not recruiting | Phase 3 | 2026-09-14 | NCT06589986 | |
| Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Sexual Dysfunctions, Psychological, Signs and Symptoms, Urinary Incontinence, Urination Disorders, Urogenital Diseases, Urogenital Neoplasms, Urological Manifestations, erectile dysfunction, male reproductive organ cancer, male reproductive system disorder, neoplasm, physiological sexual disorder, prostate cancer, prostate disorder, psychiatric disorder, urinary system disorder | Recruiting | Phase 2 | 2026-09-09 | NCT07576335 | |
| A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 / Phase 2 | 2026-08-05 | NCT06669247 | |
| The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Stroke, Acute, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-07-08 | NCT06763055 | |
| A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, urinary system disorder, viral infectious disease | Recruiting | Phase 3 | 2026-06-08 | NCT05325008 | |
| A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD | acute graft versus host disease, graft versus host disease, immune system disorder | Active, not recruiting | Phase 2 | 2026-05-26 | NCT05643638 | |
| BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation | Extracorporeal Membrane Oxygenation Complication | Recruiting | Phase 2 | 2026-05-08 | NCT05959252 | |
| Oritavancin for Treatment of Serious Cardiac Infections | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, cardiovascular disorder, endocarditis, gram-positive bacterial infections, heart disorder, infective endocarditis | Not yet recruiting | Phase 2 | 2026-04-29 | NCT07550595 | |
| Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy | Epileptic Seizures, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, nervous system disorder, visual epilepsy | Recruiting | Phase 2 | 2026-04-21 | NCT05518578 | |
| Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD) | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Recruiting | Phase 3 | 2026-03-31 | NCT04939935 | |
| Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-03-18 | NCT05636514 | |
| A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome. | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Imprinting Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Overweight, Prader-Willi syndrome, chromosomal disorder, hereditary disease, intellectual disability, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 2 | 2025-12-05 | NCT07266324 | |
| Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2025-10-28 | NCT04434807 | |
| A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease | Chronic Disease, Disease Attributes, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Recruiting | Not applicable | 2025-04-04 | NCT06122233 | |
| The Cryopreserved vs. Liquid Platelets Trial | Blood Loss, Surgical, Hemorrhage, Intraoperative Complications, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Active, not recruiting | Phase 3 | 2025-01-03 | NCT03991481 | |
| Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | COVID-19, Community-Acquired Infections, Community-Acquired Pneumonia, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, influenza, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 3 | 2024-07-12 | NCT02735707 | |
| Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), central nervous system cancer, epithelial neoplasm, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, oligodendroglioma, primitive neuroectodermal tumor | Active, not recruiting | Phase 3 | 2023-09-11 | NCT00626990 |